quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:30:00·2030d
PRRelease
KBL Merger Corp. IV logo

Groundbreaking Studies Offer Hope for Unmet Medical Needs in Inflammatory Disease

KBLM· KBL Merger Corp. IV
Finance
Full content unavailable. See the original source below.
Original source

Companies

  • KBLM
    KBL Merger Corp. IV
    Finance

Related

  • PR1991d
    KBL Merger Corp. IV Announces Completion of Acquisition of 180 Life Sciences Corp. and Trading Under the ticker ATNF Starting November 9, 2020
  • PR1994d
    KBL Merger Corp. IV Announces Approval of Business Combination with 180 Life Sciences at the Special Meeting of Shareholders Held on November 5, 2020
  • PR2008d
    KBL Merger Corp. IV Announces Change of Special Meeting of Shareholders Date to November 5, 2020
  • PR2008d
    Innovative Companies with Blockbuster Potential Catch SPAC Attention
  • PR2009d
    In Pursuit of the Elusive Drug -- the Billion-Dollar Blockbuster
  • PR2010d
    UPDATE -- The Quest for Blockbuster Drugs Continues
  • PR2018d
    Blockbuster Year and Bright Horizons for SPACs
  • PR2029d
    Life-Saving Advancements, Treatments Delivered by Companies Invested in Innovation
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022